This document discusses hypertensive disorders in pregnancy. It defines various types including gestational hypertension, chronic hypertension, preeclampsia, and eclampsia. Risk factors for preeclampsia include primigravida, family history, obesity, and diabetes. Diagnosis is based on hypertension, edema, and proteinuria. The etiology involves defective placentation leading to placental ischemia and endothelial dysfunction. Management involves controlling blood pressure, preventing complications, and timely delivery. Antihypertensives like methyldopa, labetalol and magnesium sulfate are used.
This document discusses hypertensive disorders in pregnancy. It defines various types including gestational hypertension, chronic hypertension, preeclampsia, and eclampsia. Risk factors for preeclampsia include primigravida, family history, obesity, and diabetes. Diagnosis is based on hypertension, edema, and proteinuria. The etiology involves defective placentation leading to placental ischemia and endothelial dysfunction. Management involves controlling blood pressure, preventing complications, and timely delivery. Antihypertensives like methyldopa, labetalol and magnesium sulfate are used.
Original Description:
THIIS PPT IS BASED ON HYPERTENSIVE DISORDERS IN PREGNANCY
This document discusses hypertensive disorders in pregnancy. It defines various types including gestational hypertension, chronic hypertension, preeclampsia, and eclampsia. Risk factors for preeclampsia include primigravida, family history, obesity, and diabetes. Diagnosis is based on hypertension, edema, and proteinuria. The etiology involves defective placentation leading to placental ischemia and endothelial dysfunction. Management involves controlling blood pressure, preventing complications, and timely delivery. Antihypertensives like methyldopa, labetalol and magnesium sulfate are used.
This document discusses hypertensive disorders in pregnancy. It defines various types including gestational hypertension, chronic hypertension, preeclampsia, and eclampsia. Risk factors for preeclampsia include primigravida, family history, obesity, and diabetes. Diagnosis is based on hypertension, edema, and proteinuria. The etiology involves defective placentation leading to placental ischemia and endothelial dysfunction. Management involves controlling blood pressure, preventing complications, and timely delivery. Antihypertensives like methyldopa, labetalol and magnesium sulfate are used.
PRESENTED BY RESHMA RAJ GOVT COLLEGE OF NURSING KOTTAYAM
HYPERTENSIVE DISORDERS IN PREGNANCY
Incidence 7% to 9% of all pregnancies. Varies among different hospitals, regions and countries. Pre-eclampsia- 80% and chronic hypertension - 20%.
CLINICAL CLASSIFICATION APPROVED BY THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY A. Gestational hypertension and or proteinuria
B.Chronic hypertension and Chronic Renal Disease
C.Unclassified hypertension and /or proteinuria
D. Eclampsia
NHBPEP 2000 CLASSIFIED HYPERTENSIVE DISORDERS IN PREGNANCY IN TO FIVE CATEGORIES:
GESTATIONAL HYPERTENSION Blood Pressure 140/90 on two or more occasions - at least 4 hours apart -in a previously normotensive and non proteinuria patient - after 20 weeks gestation or first 24 hrs after delivery - returning to normal 6 weeks following delivery
CHRONIC HYPERTENSION Hypertension diagnosed before pregnancy or a Blood Pressure 140/90 before 20 weeks of gestation on two occassions 6 hrs apart
CASE SCENARIO Mrs jiji ,25yrs primigravida , 32 weeks of gestation (EDC- jan 21) got admitted with c/o generalized edema and decreased urine output. Investigations Bp=160/100 urine albumin=3+ S.LDH =1380 Platelet =1.6 lakhs Uric acid =4mg/dl PT/INR =14.5/1
CASE SCENARIO Diagnosis pre eclampsia BP elevated to 200/130 inspite of emdopa and nicardia.client further managed on mgso4 and inj.labebet. EASI instilled for termination of pregnancy and she delivered a live female preterm baby of 1.5kg on 12-11-13. During postpartum period she developed severe headache BP=170/90 and continued to manage with mgso4 and nicardia.
RISK FACTORS
Primigravida younger Family history Placental abnormalities Obesity -BMI> 35 Hypercoagulability (inherited thrombophilia) Antiphospholipid syndrome(acquired thrombophilia) Black race women with diabetes, hypertension, vascular diseases,and kidney disease
Diagnostic criteria of pre-eclampsia:
Hypertension Oedema or rapid weight gain Proteinuria 0.3gm/24 hours
ETIOPATHOGENESIS OF PRE-ECLAMPSIA Defective placentation In the first trimester cytotrophoblast invades upto decidual segments.
In the second trimester invades upto the myometrial segments.
Spiral arterioles thereby become distended, tortuous and funnel shaped.
Transforms the spiral arterioles into a low resistance, low pressure, high flow system In pre eclampsia the cytotrophoblastic tissue of the placenta fails to adequately migrate down the maternal spiral arteries
Hypertension: Defective trophoplast invasion - hypoperfused placenta - release factors (growth factors,Cytokines) - endothelial injury and dysfunction- intense vasospasm Imbalance in different components of prostaglandins deficiency of vasodialator prostaglandins PGI2 and increased synthesis of thromboxane a potent vasoconstrictor Increased sensitivity to the pressor agent angiotensin II Nitric oxide deficiency contributes to hypertension
INFLAMMATORY MEDIATORS PGI2 TXA2 Vasoconstriction Platelet aggregation Vasopressor response uterine activity ETIOPATHOGENESIS OF PRE-ECLAMPSIA PROTEINURIA Spasm of the afferent glomerular arterioles
Anoxic change to the endothelium of the glomerular tuft
Glomerular endotheliosis
Increased capillary permeability
Increased leakage of proteins.
ETIOPATHOGENESIS OF PRE-ECLAMPSIA OEDEMA Increased oxidative stress
Endothelial injury
Increased capillary permeability.
Excessive accumulation of fluids in the extracellular tissue spaces
Clinical types Mild - Rise of BP of more than 140/90 mm of Hg but less than 160 mm of Hg systolic or 110 mm of Hg diastolic without significant proteinuria
Severe 1.A persistant systolic BP of160 mm hg or diastolic pressure >110 mm hg 2.excretion of >5 gm/24hrs 3.Oliguria<400 ml/24hr
CLINICAL TYPES SEVERE 4.Platelet count ,100,000 /mm3 5.HELLP syndrome 6.Cerebral or visual disturbances 7.Persistant severe epigastric pain 8.Retinal hemorrhages,exudates or papiledema 9.IUGR 10.Pulmonary edema CLASSIFICATION OF PREECLAMPSIA Mild PE Severe PE Blood pressure >140/90 >160/110 Proteinuria On 2 occasions, >4hrs apart >0.3gm/ 24 hrs Dip stic > 1+ >5gm/24 hrs Dipstic > 3+ S. creatinine normal elevated Pulmonary edema _ + oliguria _ + IUGR _ + headache _ + Visual disturbance _ + Epigastric pain _ + HELLP syndrome _ + SIGNS
Abnormal weight gain-more than 5lb a month or more than 1 lb a week 2. Rise of blood pressure usually diastolic BP tends to rise followed by systolic BP 3. Pathological Oedema. 4. Pulmonary oedema due to leaky capillaries and low oncotic pressure 5. scanty liquor 6.growth retardation of fetus
Maternal Urinalysis by dipstick 24hours urine collection Full blood count(platelets&haematocrit) Renal function(uric acid,s.creatinine,urea) Liver function tests Coagulation profile Ophthalmic examination
INVESTIGATIONS FETAL
Uss(growth parameters,fetal size,AF) 1. CTG 2. BPP 3. Doppler Complications Immediate Maternal During pregnancy During labour During Puerperium
Immediate-fetal IUD,IUGR
Remote
A LARGE SUBCAPSULAR HEMATOMA PREDICTION OF PREECLAMPSIA No screening test is really helpful Various screening methods are: Diastolic notch at 24weeks by doppler ultrasonography Absence or reversal of end diastolic flow Average mean arterial pressure 90 mmHg in second trimester Roll over test: rise in blood pressure >20 mmHg from baseline on turning supine at 28-32 weeks gestation is positive. Prophylactic measures in pre eclampsia 1) Regular antenatal check up 2) Antithrombotic agent 3) Heparin 4) Calcium supplementation 5) Antioxidants 6) Balanced diet
Management of pre eclampsia
Objectives 1) To stabilize hypertension 2) To prevent complication 3) To prevent eclampsia 4) Delivery of healthy baby 5) Restoration of the health of the mother in peuperium Home treatment 1) Rest 2) High protein diet 3) warned against the ominous symptoms as headache, visual disturbance, vomiting, epigastric pain or scanty urine
Hospital management 1) Rest in left lateral position. 2) Diet 3) Diuretics 4) Antihypertensive
ANTI HYPERTENSIVE DRUGS
DRUGS MOA SIDE EFFECTS C/I & PREVENTION Methyldopa 250mg-1g tds or 250-500mg iv Central and pripheral anti adrenergic action Maternal-postural hypotension, hemolytic anemia, sodium retention, excessive sedation Fetal-intestinal ileus Hepatic disorders, psychic pts., CCF Labetalol Oral-100mg tds till 800mg/d Iv- 20 mg till desired effect (max. 220mg) Alpha + beta blocker Maternal-tachycardia, hypotension Fetal-bradycardia, hypotension Hepatic disorders Hydralazine Oral-100mg/d in 4 divided doses Peripheral vasodilation Maternal- hypotension, tachycardia, arrythmia, palpitations, lupus like syndrome Fetal- safe Neonate- thrombocytopenia Causes sodium retention so use diuretic ANTI HYPERTENSIVES CONTD.. DRUGS MOA SIDE EFFECTS C/I & PREVENTION Nifedipine Oral: 5-10mg tds Arteriolar vasodilation Flushing, hypotension, tachycardia, inhibition of labor With MgSO4 and NMBs Nitroprusside 0.25-8 mcg/kg/min Direct vasodilator Maternal- nausea, vomitting, severe hypotension Fetal- cyanide toxicity
Seizure Prophylaxis Routinely used in severe PE Magnesium sulphate: most commonly used Initiated with onset of labor till 24h postpsrtum For caesarean, started 2hrs before the section till 12hrs postpartum Hypertensive crisis when the BP is 160/110 mm hg or the mean arterial pressure is>125 mm hg labetalol 10-20 mg IV every 10 min max of 300mg hydralazine 5mg IV q30 min max 30 mg IV nifedippine 10-20 mg oral repeated in 30 min max 240 mg/24 hr nitroglycerine 5 micro gm/min IVand sodium nitroprusside 0.25-5 mmicro gm/ kg/min IV short term therapy only when the other drugs have failed
Depending on the response to treatment the patients are grouped into: ( A ) Pre eclamptic features subside and hypertension is mild ( B ) Partial control of features, BP in steady high level
( C ) Persistantly increasing BP to serve level despite the use of antihypertensive addition of headache, epigastric pain, oliguria, blurring of vision, help syndrome
Management during labour vaginal delivery is usually attempted caesarean birth only in complication Liberal sedatives such as pethidine is given Monitor BP, hourly input and output Decrease anxiety monitor labour progress continouse electronic fetal monitoring continous iv of 5 % D5 and RL at 100-150 ml/hr prophylactic Mgso4 started when systolic BP 160 diastolic BP 110, MAP 125 mm Hg labour duration curtailed by LRM in 1 st stage and forceps and ventouse in 2 nd stage contraindication for syntocinin Methergine is withheld
Puerperium
1) Watch closely for 48 hours 2) Antihyperrtensives continued if BP systolic 150 diastolic 100 , oral nifedipine 10mg q6hrs till BP remains low for 48 hrs 3) Oral frusemide 20 mg a day for 5 days 4) MgSo4 for 24 hrs for women with severe hypertension and symptoms of acute fulminate pre eclampsia during the post partum period 5) Patient kept in hospital Till BP comes to safe level and proteinuria disappear PREECLAMPSIA SUPERIMPOSED ON CHRONIC HYPERTENSION New-onset proteinuria 300 mg/24 hours in hypertensive women but no proteinuria before 20 weeks gestation A sudden increase in proteinuria or blood pressure or platelet count <1 lakh/mm 3 in women with hypertension and proteinuria before 20 weeks gestation More adverse outcome than preeclampsia alone
HELLP SYNDROME This is an acronym for:- 1) Haemolysis 2) Elevated liver enzymes 3) Low platelet count ( <100,000/mm 3 ) 4) Its a rare complication of pre eclampsia which develop even without maternal hypertension 5) Its manifested by nausea, vomiting, epigastric or right upper quadrant pain, with haematological and biochemical changes.
Management 1) Same as that of pre eclampsia 2) Anti seizure prophylaxis with MgSo4 3) Corticosteroids 4) Caesarean section 5) Epidural aneasthesia if platelet>1,00,000/mm 3
6) Platelet transfusion if count < 50,000/ mm 3
7) Expectant management done when pregnancy <34 weeks with bed rest, Plasma volume expansion, anti Thrombotic agents, immunosuppressive agents
ECLAMPSIA Definition Its a Greek word meaning like a flash of lightening occur abruptly without any warning manifestations Pre eclampsia when complicated with generalized tonic clonic convulsion and/or coma is called eclampsia
Incidence Varies widely from country to country and even between different zones of the same country.
In India ranges from 1 in 500 to 1 in 30.
Its more common in primigravidae,
5 times more common in twins,
Cause of convulsion
Cerebral irritation provoked by anoxia , cerebral edema cerebral dysrhythmia. There is excessive release of excitatory neurotransmitters (glutamate).
EPIDEMIOLOGY 0.1- 5.5 per 10,000 pregnancies Decreasing incidence with time Antepartum(50%): mostly in third trimester Intrapartum(30%): Postpartum(20%): usually within 48hours, fits beyond 7days generally rules out eclampsia
CLINICAL FEATURES Eclamptic convulsions consist of four stages Premonitory stage: twitching of muscles of face, tongue, limbs and eye. Eyeballs rolled or turned to one side, 30s Tonic stage: opisthotonus, limbs flexed, hands clenched, 30s Clonic stage: 1-4 min, frothing, tongue bite, stertorous breathing Stage of coma: variable period.
First aid treatment outside the hospital 1) Shifted urgently 2) Needs neonatal and obstetrical intensive care 3) All records and detailed summary 4) BP stabilized and convulsion arrested 5) Magnesium sulfate 4gm IV loading dose with 10gm IM 6) Labetalol 20mg IV for hypertension 7) Diuretics if pulmonary edema 8) Diazepam 5mg slowly over 1 min for apnea and cardiac arrest 9) Trained midwife
In Hospitals-principles followed 1) Maintain ABC 2) Oxygen administration 8-10 ltr/min 3) Arrest convulsion ventilator support prevention of injury 4) Haemodynamic stabilization 5) Organize investigation 6) Delivery 6-8 hours 7) Prevention of complications 8) Postpartum care
General management Supportive care Keep in a railed cot, Tongue blade is inserted between the teeth, Lateral decubitus position, Frequent suctioning, Face mask 8-10l/min,
Arterial blood gas analysis Sodium bicarbonate is given when the ph is below 7 Constant supervision Detailed history is to be taken Balanced salt solution 1 ml/kg per hour Dextrose or crystalline solutions should not be used-calculate fluid Quick general abdominal and vaginal examinations are made Self retaining catheter Urine is tested for protein Half hourly pulse BP are recorded Hourly urinary output, Uterus should be palpated Fetal heart rate Fluid balance CVP monitoring Antibiotic
Specific management Anticonvulsant and sedative Magnesium sulphate is the drug of choice Antihypertensive and diuretics
RECOMMENDED REGIME FOR MGSO 4
Zuspan or sibai regime: 4-6 gm i.v over 15 min f/b infusion of 1-2 gm/hr
Pritchard regime: 4 gm i.v over 3-5min f/b 5 gm in each buttock with maintenance of 5 gm i.m in alternate buttock 4 hrly
Care of patients receiving mgso4 Explain reason for use Reactions to expect from medication Monitor to anticipate Administration Maternal and fetal assessment Reportable conditions Emergency measures Documentation
Other regimens are 1) Lytic cocktail using chlorpromazine, promethazine and pethadine 2) Diazepam 3) Phenytoin
Management during fit 1) A mouth gag placed 2) Air passage cleared off 3) Head turned to one side pillow taken off 4) Raising foot end of bed facilitates postural drainage 5) Oxygen is given until cyanosis is disappeared
Status epilepticus- Thiopentone sodium Antibiotics Frusemide followed by mannitol Aspiration of the mucous Oxygen inhalation ,parenteral lasix and digitalis
STATUS EPILEPTICUS
Dopamine infusion Cold sponge and antipyretics Chlorpromazine or eskazine Intensive care monitoring Blood sugar analyse Central venous pressure monitoring Steroids and diuretic therapy Obestric management
Follow up and Prognosis. 1) six week time 2) Persistence of hypertension proteinurea abnormal blood biochemistry necessitates consultation with physician. 3) Further pregnancy should be deferred till they are controlled. 4) Recurrence risk varies between 2-25 %. 5) Atiypical eclampsia is defined when eclampsia occurs 20 th weeks of pregnancy or more than 48 hours postpartum treated with parental magnesium sulphate.
ESSENTIAL HYPERTENSION IN PREGNANCY
Incidence varies from 1-3%. Diagnosis criteria 1) Rise of BP of 140/90mm of hg during pregnancy prior to the 20 th
week 2) Cardiac enlargement 3) Presence of medical disorders 4) Persistent rise of BP even after 42 days following delivery
MANAGEMENT: The principles of management are: To stablised the blood pressure to below 160/100 mm of Hg. To prevent superimposed of pre-eclampsia To monitor the maternal the and fetal well being. To terminate pregnancy at the optimal time.
GENERAL MANAGEMENT
In mild cases with blood pressure less than 160/100 mm of Hg, adequate rest ,low salt diet The check up should be more frequent 1- 2 weeks interval up to 28 weeks and thereafter weekly.
In severe cases ,the patient should be hospitalized Antihypertensive Drugs: Benefit the mother but reduce the placental perfusion. Obsteric management: In mild cases, spontaneous labour is awaited.
In severe or complicated cases, try to continue till 34 weeks or till 37 week for fetal maturity and terminate. Nursing assessment Cardiovascular Renal Central nervous system Pulmonary Hepatic Hematology Reproductive Fetal surveillance
DEGREES OF EDEMA Risk for imbalanced less than body requirements related to insufficient intake to meet metabolic demands and replace losses Knowledge deficit regarding condition, prognosis, self care and treatment related to lack of exposure/unfamiliarity with information resources, misinterpretation
Ineffective individual/family coping related to woman restricted activity and concern over a complicated pregnancy.
Powerlessnessness related to inability to prevent or control condition and outcome